{"id":"W2042692879","doi":"10.1002/cncr.22996","title":"A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Prostate cancer; Placebo; Urology; Peripheral edema; Hazard ratio; Oncology; Adverse effect; Gastroenterology; Randomized controlled trial; Surgery; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002433035,0.0011636,0.002445415,0.0002885157,0.0004420294,0.0007478459,0.0007791485,0.001185294,0.006795253],"category_scores_gemma":[0.001853029,0.0004947617,0.001329817,0.0003332864,0.0008181371,0.0006809121,0.0002881289,0.002248625,0.0006726925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005391283,"about_ca_system_score_gemma":0.0015091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007556022,"about_ca_topic_score_gemma":0.002347621,"domain_scores_codex":[0.9992257,0.0005061349,0.00004145988,0.000110078,0.00005334125,0.00006328452],"domain_scores_gemma":[0.9988772,0.0003670354,0.0003095558,0.00008198449,0.00006763466,0.0002965658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.978672,0.004618138,0.0007304829,0.0004832021,0.0008150926,0.00003848914,0.00004044621,0.000227361,0.002559227,0.00006468101,0.0005523061,0.01119868],"study_design_scores_gemma":[0.9506627,0.04673946,0.001506675,0.00001828037,0.0002422791,0.00003168931,0.000009536478,0.0001988554,0.0002152622,0.00005961936,0.0003088795,0.000006764987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845771,0.00572683,0.0007529798,0.0006833621,0.0003683802,0.004922044,0.001087215,0.0001341255,0.001747864],"genre_scores_gemma":[0.9849947,0.002761486,0.00203091,0.001219827,0.0003461613,0.005642863,0.001020007,0.00002222468,0.001961704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006795253,"threshold_uncertainty_score":0.02273238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01891782803452224,"score_gpt":0.3564106759370143,"score_spread":0.3374928479024921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}